Another “Amniotic Fluid/Umbilical Cord Blood/Wharton’s Jelly, Exosome” Sales Company Gets Stopped By The FDA
This time, the company is RichSource Stem Cells, whose CEO is Sara Oracle. On November 20, 2019, the FDA sent the company a letter detailed all of the falsehoods in the claims being mad by these companies when they sell their products to clinicians….and all the falsehoods that clinicians are selling patients when then sell these products.